Skip to main content

FDA

By Jonah Comstock | 04:02 pm | October 10, 2018
The FDA’s Pre-Cert program has fallen under new scrutiny as the agency received an open letter today from three senators: Elizabeth Warren (D-Mass.
By Dave Muoio | 04:18 pm | October 01, 2018
In a statement, Dr. Scott Gottlieb detailed his agency’s ongoing cybersecurity efforts, which include the signing of two “significant memoranda of understanding” and discussions to facilitate collaboration across government agencies.
By Jonah Comstock | 03:05 pm | September 26, 2018
A robust investigation published in Diabetes Care looked at 18 top-selling meters, making up 90 percent of the market.
By Jonah Comstock | 11:32 am | September 17, 2018
The results to our poll about the FDA program prompt questions about the program's fairness to companies big and small.
By Jonah Comstock | 05:10 pm | September 13, 2018
The announcement has drawn questions about novelty and claims of coziness with the FDA.
By Jonah Comstock | 03:16 pm | September 12, 2018
This is the first FDA clearance for Apple and pushes the Watch further into healthcare than ever before.
By Dave Muoio | 12:35 pm | September 11, 2018
The KardiaK Software Platform could be used with mobile ECG devices to identify potential cases of kidney disease.
By Bradley Merrill Thompson | 12:20 pm | September 07, 2018
Epstein Becker & Green's Bradley Merrill Thompson says the FDA's much-touted program is riddled with unseen costs and unanswered questions.
By Jonah Comstock | 04:51 pm | August 23, 2018
Online patient community PatientsLikeMe, which connects patients with different symptoms and conditions and collects patients' voluntarily submitted data for research, has teamed up with the FDA on a research study that could point the way toward a new channel for patient-generated health data for the agency.
By Dave Muoio | 04:29 pm | August 23, 2018
As laid out in the 21st Century Cures Act, the Breakthrough Devices Program looks to streamline new medical technologies that offer improved treatment for serious diseases.